Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 314 of the 339 references it cites were found in a registry or an index; 38 of the 131 sources its claims cite were checked for support.

Clinical magnetocardiography: the unshielded bet—past, present, and future

Open access
Brisinda, D., Fenici, P., Fenici, R. · 2023 · Frontiers in Cardiovascular Medicine

Abstract

Magnetocardiography (MCG), which is nowadays 60 years old, has not yet been fully accepted as a clinical tool. Nevertheless, a large body of research and several clinical trials have demonstrated its reliability in providing additional diagnostic electrophysiological information if compared with conventional non-invasive electrocardiographic methods. Since the beginning, one major objective difficulty has been the need to clean the weak cardiac magnetic signals from the much higher environmental noise, especially that of urban and hospital environments. The obvious solution to record the magnetocardiogram in highly performant magnetically shielded rooms has provided the ideal setup for decades of research demonstrating the diagnostic potential of this technology. However, only a few clinical institutions have had the resources to install and run routinely such highly expensive and technically demanding systems. Therefore, increasing attempts have been made to develop cheaper alternatives to improve the magnetic signal-to-noise ratio allowing MCG in unshielded hospital environments. In this article, the most relevant milestones in the MCG's journey are reviewed, addressing the possible reasons beyond the currently long-lasting difficulty to reach a clinical breakthrough and leveraging the authors' personal experience since the early 1980s attempting to finally bring MCG to the patient's bedside for many years thus far. Their nearly four decades of foundational experimental and clinical research between shielded and unshielded solutions are summarized and referenced, following the original vision that MCG had to be intended as an unrivaled method for contactless assessment of the cardiac electrophysiology and as an advanced method for non-invasive electroanatomical imaging, through multimodal integration with other non-fluoroscopic imaging techniques. Whereas all the above accounts for the past, with the available innovative sensors and more affordable active shielding technologies, the present demonstrates that several novel systems have been developed and tested in multicenter clinical trials adopting both shielded and unshielded MCG built-in hospital environments. The future of MCG will mostly be dependent on the results from the ongoing progress in novel sensor technology, which is relatively soon foreseen to provide multiple alternatives for the construction of more compact, affordable, portable, and even wearable devices for unshielded MCG inside hospital environments and perhaps also for ambulatory patients.

Overview

CoChat Summary

TL;DR

This review traces 60 years of clinical magnetocardiography (MCG), contrasting shielded and unshielded systems and drawing on the authors’ four decades of experience. It argues that unshielded MCG is feasible and clinically informative, and that advances in sensors, active shielding, and denoising may finally bring it to the patient’s bedside.

Key findings

  • Unshielded MCG has been demonstrated since 1980; the first 36-channel unshielded system became operational in January 2002, with raw peak-to-peak background noise of 7–30 pT, 1–2 pT after adaptive 50 Hz filtering, sensitivity of 20–40 fT/√Hz above 1 Hz, source-localization reproducibility ICC >0.7, and quasi-real-time mapping in 90 s with analysis in less than 2 min.
  • Localization accuracy: single-channel unshielded MCG gave average 3D uncertainty of about 12 mm in patients and about 5 mm in phantom; shielded Neuromag MCG with amagnetic catheters gave 2 ± 0.7 mm SD in a realistic torso phantom and 4 ± 2.7 mm SD in patients, about twice as good as simultaneous body surface potential mapping.
  • Clinical targets discussed include emergency triage of chest pain, ischemic and non-ischemic cardiomyopathies, heart transplant rejection, non-invasive 3D electroanatomical imaging of arrhythmogenic substrates, fetal MCG, and animal studies; newer systems include Avalon-H90, VitalScan/Corsens, and CardioFlux, while a multicenter ACS study concluded VitalScan did not yet meet accuracy to confidently rule out ACS in the ED in 2020.
  • Emerging sensor/denoising results include scalar OPM gradiometers with <90 fT/√Hz equivalent to 18 fT/cm/√Hz at 5 cm baseline, another with 16 fT/cm/Hz1/2 at 3 cm baseline, and EEMD denoising improving SNR by approximately 18 dB with r = 0.9 between shielded and unshielded MCG after processing.

Methods

  • Narrative review, not a systematic review or meta-analysis, synthesizing referenced experimental and clinical MCG literature with the authors’ personal experience since the early 1980s in shielded and unshielded settings.
  • Sources include clinical studies, multicenter trials, conference proceedings, device-development reports, and validation work using systems such as CMI 3619a, Neuromag, amagnetic catheters, phantoms, and patient recordings.
  • No formal primary data collection or quantitative synthesis is reported; the analysis is a qualitative historical and technical comparison of shielded versus unshielded MCG and of sensor, shielding, and denoising technologies.

Limitations

  • Stated in the paper: lack of standardization of MCG acquisition, postprocessing, and analysis makes studies only partially comparable and less sharable; dedicated software for MCG 3D electroanatomical imaging is still lacking relative to ECGi; some new sensors still require electromagnetic shielding or have lower sensitivity; scalar OPMs are costly (about $15K per gradiometer unit, more than one order of magnitude higher than the present average cost of a SQUID); wearable MCG may suffer movement artifacts; and OPMs developed for MEG need evaluation for deeper cardiac source localization.
  • Evident from the text: the review is authored by long-standing proponents of unshielded MCG and relies heavily on their own center’s experience, with no described systematic search or selection criteria, so selection and enthusiasm bias are possible.
  • Evident from the text: many cited future or ongoing developments, including ongoing trials and not-yet-commercial sensors, are not yet clinically validated for widespread MCG use.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.3389/fcvm.2023.1232882

Cites

314 of 315 references verified1 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Figures

Figure 1 (A) CNR's physicist Gian Luca Romani (left) and Riccardo Fenici (right) testing the prototype of the CNR unshielded MCG SQUID gradiometer at the Catholic University's Gemelli Hospital in Rome. (B) Example of real-time simultaneous MCG and ECG recordings and (C) example of 36-position real-time single-beat MCG recordings (Finnish grid) [modified from (98)].
Figure 1 (A) CNR's physicist Gian Luca Romani (left) and Riccardo Fenici (right) testing the prototype of the CNR unshielded MCG SQUID gradiometer at the Catholic University's Gemelli Hospital in Rome. (B) Example of real-time simultaneous MCG and ECG recordings and (C) example of 36-position real-time single-beat MCG recordings (Finnish grid) [modified from (98)].CC BY · PubMed Central
Figure 2 Unshielded magnetocardiography at the Catholic University Hospital's BACPIC: (A) Single-channel system; (B) Nine-channel CMI prototype; (C) CMI 3619a 36-channel; and (D) examples of real-time MCG recordings and of the signal processing flow chart for MF imaging and 3D source localization.
Figure 2 Unshielded magnetocardiography at the Catholic University Hospital's BACPIC: (A) Single-channel system; (B) Nine-channel CMI prototype; (C) CMI 3619a 36-channel; and (D) examples of real-time MCG recordings and of the signal processing flow chart for MF imaging and 3D source localization.CC BY · PubMed Central
Figure 3 (A) High-resolution MCG map of the “ramp-like” pattern during the PR interval with superimposed isomagnetic lines [modified from (120) data]. (B) Validation of the atrial repolarization nature of the PR “ramp-like” MCG pattern with simultaneous MCG and atrial monophasic action potential recording. The red asterisk indicates the His bundle MF (±0.2pT) disclosed during the last half of the PR interval after subtraction of the stronger (±1.8 pT) atrial repolarization MF (open red arrow). The pseudo-current reconstruction (multiple white arrows on the MF maps) indicates the opposite direction of atrial and His bundle depolarization current and of atrial repolarization current [standardized MF color code: in blue (−), MF outgoing from the chest; in red (+), MF entering in the chest].
Figure 3 (A) High-resolution MCG map of the “ramp-like” pattern during the PR interval with superimposed isomagnetic lines [modified from (120) data]. (B) Validation of the atrial repolarization nature of the PR “ramp-like” MCG pattern with simultaneous MCG and atrial monophasic action potential recording. The red asterisk indicates the His bundle MF (±0.2pT) disclosed during the last half of the PR interval after subtraction of the stronger (±1.8 pT) atrial repolarization MF (open red arrow). The pseudo-current reconstruction (multiple white arrows on the MF maps) indicates the opposite direction of atrial and His bundle depolarization current and of atrial repolarization current [standardized MF color code: in blue (−), MF outgoing from the chest; in red (+), MF entering in the chest].CC BY · PubMed Central
Figure 4 Example of multimodal 3D EAI based on MSI validated in the Helsinki University Central Hospital's BioMag Laboratory. (A) The MSR. (B) Fluoroscopic imaging of two amagnetic catheters (ACs). (C) MRI imaging. (D) 3D localization of the distal end of the ACs with the MCG ECD inverse solution. (E) 3D current density imaging of two 10 µA current dipoles generated by the ACs. (F) Multiple monophasic action potential recordings from the ACs.
Figure 4 Example of multimodal 3D EAI based on MSI validated in the Helsinki University Central Hospital's BioMag Laboratory. (A) The MSR. (B) Fluoroscopic imaging of two amagnetic catheters (ACs). (C) MRI imaging. (D) 3D localization of the distal end of the ACs with the MCG ECD inverse solution. (E) 3D current density imaging of two 10 µA current dipoles generated by the ACs. (F) Multiple monophasic action potential recordings from the ACs.CC BY · PubMed Central
Figure 5 Example of non-invasive MCG localization of a right posterior-septal Kent bundle during sustained antidromic reentry tachycardia induced by transesophageal atrial pacing and spontaneous desynchronization in atrial fibrillation. The accessory pathway localization was confirmed by successful RF ablation.
Figure 5 Example of non-invasive MCG localization of a right posterior-septal Kent bundle during sustained antidromic reentry tachycardia induced by transesophageal atrial pacing and spontaneous desynchronization in atrial fibrillation. The accessory pathway localization was confirmed by successful RF ablation.CC BY · PubMed Central
Figure 6 Typical experimental setup used for the MCG study of small animals with the CMI 3649a system. (A) Non-invasive contactless MCG recording and source imaging. (B) Procedure for simultaneous minimally invasive electrophysiological study with a single AC for multiple monophasic action potential recording from the epicardial surface, localizable with the MCG mapping and EMD inverse solution [red-circled solid arrow in (C)].
Figure 6 Typical experimental setup used for the MCG study of small animals with the CMI 3649a system. (A) Non-invasive contactless MCG recording and source imaging. (B) Procedure for simultaneous minimally invasive electrophysiological study with a single AC for multiple monophasic action potential recording from the epicardial surface, localizable with the MCG mapping and EMD inverse solution [red-circled solid arrow in (C)].CC BY · PubMed Central
Figure 7 Examples of most recent novel MCG devices, two operating unshielded: (A) the cryogenic Avalon-H90. (B) The portable VitalScan/Corsens and one still requiring local EMS provided by a more compact cylindric MSR. (C) The CardioFlux, featuring zero-field OPMs.
Figure 7 Examples of most recent novel MCG devices, two operating unshielded: (A) the cryogenic Avalon-H90. (B) The portable VitalScan/Corsens and one still requiring local EMS provided by a more compact cylindric MSR. (C) The CardioFlux, featuring zero-field OPMs.CC BY · PubMed Central
Figure 8 First reported comparison between sequential 36-point MCG recording with a single-channel OPM developed at the University of Freiburg (Swiss) and 36-channel MCG mapping at the Catholic University Hospital in Rome. All data were converted to the same format and analyzed with the Neuromag MCG software. The identity of MCG waveforms, of the MF distribution, of the related source localization (green arrows onto the MF maps), and of the 3D current density imaging (CDI), calculated at the apex of the QRS and of the T waves, is immediately evident [modified from data in (275)].
Figure 8 First reported comparison between sequential 36-point MCG recording with a single-channel OPM developed at the University of Freiburg (Swiss) and 36-channel MCG mapping at the Catholic University Hospital in Rome. All data were converted to the same format and analyzed with the Neuromag MCG software. The identity of MCG waveforms, of the MF distribution, of the related source localization (green arrows onto the MF maps), and of the 3D current density imaging (CDI), calculated at the apex of the QRS and of the T waves, is immediately evident [modified from data in (275)].CC BY · PubMed Central
Figure 9 First reported test of a dual-channel scalar field OPMs (geometrics MFAM) arranged as a first-order gradiometer (baseline 5 cm) in the Catholic University Hospital's unshielded BACPIC: (A) Preliminary phantom measurement of a 1 mA current dipole generated by the amagnetic catheter. (B) Comparison between MCG recording and CMI 36-channel MCG mapping (R-wave MF distribution). The similarity of MCG waveforms recorded with the MFAM (B1) and with the SQUID (B2) at the same grid position (white circle onto the MF map) is evident. The amplitude of the MCG signal recorded with the MFAM is higher because the OPMs can be placed closer to the chest. (C) Noise spectra of each MFAM and of the first-order gradiometer.
Figure 9 First reported test of a dual-channel scalar field OPMs (geometrics MFAM) arranged as a first-order gradiometer (baseline 5 cm) in the Catholic University Hospital's unshielded BACPIC: (A) Preliminary phantom measurement of a 1 mA current dipole generated by the amagnetic catheter. (B) Comparison between MCG recording and CMI 36-channel MCG mapping (R-wave MF distribution). The similarity of MCG waveforms recorded with the MFAM (B1) and with the SQUID (B2) at the same grid position (white circle onto the MF map) is evident. The amplitude of the MCG signal recorded with the MFAM is higher because the OPMs can be placed closer to the chest. (C) Noise spectra of each MFAM and of the first-order gradiometer.CC BY · PubMed Central

Verification

Claims the paper makes

18 Valid · 19 Not valid · 34 Not checked · 24 Own results and interpretations

36 more claims · 4 with their cited sources checked

Create a free account to see all 95 claims and to verify the 8 references still open.

See all claims — free account
  • It may state two separate claims as one. 40
  • Probably not a substantial claim. 17

Create a free account to see these claims.

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

Each contradiction between two passages listed here was confirmed by an independent check.

1 of 1

Citations

Cites

Show all 339 references

Research works printed but not linked: 12

  1. Cohen, 1970, Magnetocardiograms taken inside a shielded room with a superconducting point-contact magnetometer, Appl Phys Lett, 16, 80, 10.1063/1.1653195 · DOI · Paper page
  2. Stroink, 1989, Principles of cardiomagnetism, 47, 10.1007/978-1-4613-0581-1_4 · DOI · Paper page
  3. Stroink, 1998, Magnetism in medicine: a handbook, chapter cardiomagnetism
  4. Siltanen, 1989, Magnetocardiography, 1405
  5. Erne, 1985, Modelling of the His-Purkinje heart conduction system, 126
  6. Fenici, 1985, First simultaneous magnetocardiographic and invasive recordings of the PR interval electrophysiological phenomena in man, Med Biol Eng Comput, 23, 1483
  7. Dössel, 2000, Inverse problem of electro- and magnetocardiography: review and recent progress, Int J Bioelectromagn, 2, 262
  8. Fenici, 1989, Biomagnetic imaging in the cardiac catheterization laboratory, 409, 10.1007/978-1-4613-0581-1_87 · DOI
  9. Pesola, 1997, Comparison of regularization methods when applied to epicardial minimum norm estimates, Biomed Tech, 42, 273
  10. Fenici, 2001, First MCG multichannel instrumentation operative in an unshielded hospital laboratory for multimodal cardiac electrophysiology. Preliminary experience, Biomed Tech, 2019
  11. Park, 2005, Magnetocardiography predicts coronary artery disease in patients with acute chest pain, Ann Noninvasive Electrocardiol, 10, 312, 10.1111/j.1542-474X.2005.00634.x · DOI · Paper page
  12. Petrenko, 2022, Towards a practical implementation of a single-beam all-optical non-zero-field magnetic sensor for magnetoencephalographic complexes, Sensors, 22, 9862, 10.3390/s22249862 · DOI · Paper page

Cited by

See all 80

Metadata

Authors
Brisinda, D., Fenici, P., & Fenici, R.
Affiliations
Università Cattolica del Sacro Cuore (IT)
Corresponding author
Fenici, R.
Venue
Frontiers in Cardiovascular Medicine
Published
2023-08-10
Volume
10
Pages
1232882-1232882
ISSN
2297-055X (ISSN-L)
OpenAlex
W4385724211
Cited by
80
References
339
Citations by year
2026: 30 · 2025: 30 · 2024: 18 · 2023: 2
FWCI
3.91
Type
journal article
Language
en
Open access
Locations
  • Frontiers in Cardiovascular Medicine (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • PubliCatt (Università Cattolica del Sacro Cuore) (submittedVersion, cc-by)
Funders
  • Università degli Studi di Parma
  • Università Cattolica del Sacro Cuore
Topics
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › ECG Monitoring and Analysis
  • Physical Sciences › Physics and Astronomy › Atomic and Molecular Physics, and Optics › Atomic and Subatomic Physics Research
  • Physical Sciences › Engineering › Electrical and Electronic Engineering › Magnetic Field Sensors Techniques
Keywords
magnetocardiography, magnetic shielding, signal-to-noise ratio, cardiac electrophysiology, wearable sensors, clinical adoption

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

The claim verdicts this report counts are experimental: their accuracy is not yet measured.

A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (gpt-6-sol).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Clinical magnetocardiography: the unshielded bet—past, present, and future. https://app.cochat.ai/papers/10.3389/fcvm.2023.1232882
The paper
Brisinda, D., Fenici, P., & Fenici, R. (2023). Clinical magnetocardiography: the unshielded bet—past, present, and future. Frontiers in Cardiovascular Medicine. https://doi.org/10.3389/fcvm.2023.1232882

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.